- Home
- EXEL vs DTM Comparison
EXEL vs DTM Comparison
Compare EXEL & DTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EXEL | DTM |
|---|---|---|
| Founded | 1994 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 12.3B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | EXEL | DTM |
|---|---|---|
| Price | $44.47 | $122.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 11 |
| Target Price | $45.45 | ★ $124.91 |
| AVG Volume (30 Days) | ★ 2.2M | 614.0K |
| Earning Date | 02-10-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 2.68% |
| EPS Growth | ★ 53.55 | N/A |
| EPS | 2.38 | ★ 3.96 |
| Revenue | ★ $2,288,218,000.00 | $1,175,000,000.00 |
| Revenue This Year | $9.74 | $27.83 |
| Revenue Next Year | $12.27 | $8.45 |
| P/E Ratio | ★ $18.63 | $30.89 |
| Revenue Growth | 9.93 | ★ 20.39 |
| 52 Week Low | $31.90 | $83.30 |
| 52 Week High | $49.62 | $122.70 |
Technical Indicators
Market Signals| Indicator | EXEL | DTM |
|---|---|---|
| Relative Strength Index (RSI) | 52.18 | 61.43 |
| Support Level | $43.00 | $116.82 |
| Resistance Level | $45.41 | $122.70 |
| Average True Range (ATR) | 1.65 | 2.59 |
| MACD | -0.09 | 0.24 |
| Stochastic Oscillator | 58.22 | 91.03 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About DTM DT Midstream Inc.
DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.